Author: CV Journalist
-
Johnson & Johnson’s single-shot Covid-19 vaccine to have its trial commenced in India
World’s only manufacturer with the single-dose vaccine against Covid-19, US-based pharma giant Johnson & Johnson, has communicated to Indian regulators that it would soon ... -
Centre calls for vaccinating vulnerable people on priority & not those who ‘want it’, labels next 4 weeks critical in India’s Covid-19 surge
With India recording the highest ever daily Covid-19 cases count, many sections of societies and leaders have urged the government to expand the age ... -
Delhi Coronavirus: Kejriwal Calls for an emergency meeting as capital witnesses 53% surge in cases
Delhi Chief Minister Arvind Kejriwal calls for an emergency meeting with his party officials and Health Minister Satyendar Jain to set up a strong ... -
BMC announces to provide 2,269 beds in private hospitals amid Covid surge in Maharashtra
On Tuesday, Mumbai’s Brihan Municipal Corporation (BMC) declared that the civic body will produce 2,269 beds for coronavirus along with 360 ICU beds, in ... -
Explained: Can India’s second Covid-19 wave be more devastating than the first
India is witnessing the second wave of Covid-19 with a number of new cases surpassing the previous day’s number. But the most critical part ... -
The recent surge in Coronavirus cases in India & are variants present the cause: Explained
Past few weeks have witnessed a massive surge in the number of Coronavirus cases in India. Scientists across the country studied samples from the ... -
Government committee establishes no blood clot risk from Covaxin and Covishield
There is no increased risk of blood clotting post vaccination with Covaxin and Covishield so far, ruled top government committee. The top committee came ... -
US to financially assist India’s COVID-19 vaccine production
US is going to financially support Indian drugmaker Biological E to produce COVID-19 vaccines In a major boost to the ongoing battle against the ... -
India: Centre declares Bharat Biotech’s Covaxin is now taken off ‘clinical trial mode’
Bharat Biotech’s Covaxin is now taken off the clinical trial mode, the Central Government announces on Thursday. Moreover, now the vaccine beneficiaries won’t need ... -
India begins second vaccination round for 60+ and 45+ with co-morbidities, online registration open
Starting from March 1, India’s second round of vaccination is beginning against Covid-19 for people over 60 years of age and for people over ...
